Crescent Pharma recalls Ramipril 2.5 mg Capsules due to packaging error
Crescent Pharma Limited is recalling a batch of Ramipril 2.5 mg Capsules due to a potential packaging error.
Signal
Crescent Pharma recalls Ramipril 2.5 mg Capsules due to packaging error
Company
Crescent Pharma Limited
Category
Strategy
Therapeutic Area
Cardiovascular / ACE Inhibitor
Action
Monitor
Signal assessment
Signal strength
high
Confidence level
high
Why it matters
The recall of Ramipril 2.5 mg Capsules due to a packaging error poses significant risks to Crescent Pharma's market reputation and sales within the cardiovascular segment. Portfolio teams must closely monitor the situation and prepare strategies to address potential reputational damage.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor for updates on the recall process and any regulatory actions that may follow.
Related companies & assets
Companies
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.